SEC Form 4 · accession 0001127602-15-004348
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wayne Wilson
Director
Period of report
Jan 31, 2015
Accepted (ET)
Feb 4, 2015 · 4:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 31, 2015 | A | 12,500 | $0.00 | A | 113,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $6.45 | Jan 31, 2015 | A | 25,000 | A | — | Jan 31, 2025 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The stock options vest as to one-fourth of the options on each of March 31, 2015, June 30, 2015, September 30, 2015, and December 31, 2015.